• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子设备评估日常体力活动的有效性。

Validity of cardiac implantable electronic devices in assessing daily physical activity.

机构信息

Department of Prevention and Sports Medicine, Technische Universität München, Connollystr. 32, 80809 Munich, Germany.

出版信息

Int J Cardiol. 2013 Sep 30;168(2):1127-30. doi: 10.1016/j.ijcard.2012.11.050. Epub 2012 Nov 30.

DOI:10.1016/j.ijcard.2012.11.050
PMID:23201084
Abstract

BACKGROUND

Data on physical activity assessed by cardiac implantable electronic devices (ICD/CRT) have been used for prognostic implications in heart failure patients, but no study has ever compared these data to validated external accelerometers.

METHODS

73 ICD/CRT recipients (age 60 ± 20 years, 21% female) received a validated external accelerometer over a period of 7 days. Thereafter, data on physical activity of both ICD/CRT and external accelerometers were retrieved and compared using Spearman's rank correlation coefficient and Bland Altman plots.

RESULTS

Mean total daily activity was 276 ± 85 min (range 72-462) as assessed by the external accelerometers and 237 ± 105 min (28-575) as assessed by the ICD/CRT activity sensors (p<0.001). A strong, significant intra-individual correlation (r>0.7) between the two measurements was observed in a majority (70%) of patients (p<0.05 each). However, a Bland Altman plot revealed a broad variation of total daily activity between both methods (95% limits of agreement -225 to 147 min), resulting in differences in the duration of daily activity up to several hours. In multivariate regression analysis, no influence of age, NYHA functional class, left ventricular ejection fraction, underlying disease or type of device on these differences was observed.

CONCLUSIONS

As compared to a validated external accelerometer, daily physical activity assessed by ICD/CRT devices shows strong intra-individual correlations, but differs substantially regarding the absolute amount of daily activity. Thus, using ICD/CRT activity data for more precise clinical or prognostic information without prior validation is of limited value.

摘要

背景

通过心脏植入式电子设备(ICD/CRT)评估的身体活动数据已用于心力衰竭患者的预后评估,但尚无研究将这些数据与经过验证的外部加速度计进行比较。

方法

73 名 ICD/CRT 患者(年龄 60±20 岁,21%为女性)佩戴经过验证的外部加速度计 7 天。此后,检索并比较了 ICD/CRT 和外部加速度计的身体活动数据,使用 Spearman 秩相关系数和 Bland-Altman 图进行比较。

结果

外部加速度计评估的平均每日总活动量为 276±85 分钟(范围 72-462),而 ICD/CRT 活动传感器评估的为 237±105 分钟(28-575)(p<0.001)。大多数(70%)患者的两种测量方法之间存在较强的、显著的个体内相关性(r>0.7)(p<0.05 各)。然而,Bland-Altman 图显示两种方法之间的总日常活动量存在广泛差异(95%一致性界限为-225 至 147 分钟),导致每日活动时间的差异可达数小时。多元回归分析显示,年龄、NYHA 功能分级、左心室射血分数、基础疾病或设备类型对这些差异无影响。

结论

与经过验证的外部加速度计相比,ICD/CRT 设备评估的日常身体活动具有较强的个体内相关性,但在日常活动量的绝对值上存在显著差异。因此,在没有事先验证的情况下,使用 ICD/CRT 活动数据来获取更精确的临床或预后信息的价值有限。

相似文献

1
Validity of cardiac implantable electronic devices in assessing daily physical activity.心脏植入式电子设备评估日常体力活动的有效性。
Int J Cardiol. 2013 Sep 30;168(2):1127-30. doi: 10.1016/j.ijcard.2012.11.050. Epub 2012 Nov 30.
2
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
3
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.心力衰竭男性和女性心脏再同步和植入式心脏复律除颤器治疗的临床效果:来自 IMPROVE HF 的研究结果。
Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.
4
Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.心脏再同步治疗对充血性心力衰竭患者疾病进展的影响。
Ital Heart J. 2004 May;5(5):364-70.
5
Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.晚期慢性心力衰竭患者接受心脏再同步治疗后纽约心脏协会心功能分级改善的临床预测因素及时间:多中心InSync随机临床评估(MIRACLE)和多中心InSync植入式心脏除颤器随机临床评估(MIRACLE-ICD)试验结果
Am Heart J. 2006 Apr;151(4):837-43. doi: 10.1016/j.ahj.2005.06.024.
6
Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.接受心脏再同步治疗的植入式除颤器患者中恰当除颤治疗的预测因素。
J Cardiovasc Electrophysiol. 2006 May;17(5):486-90. doi: 10.1111/j.1540-8167.2006.00355.x.
7
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.比较心力衰竭和射血分数降低的门诊心脏病学患者在有无器械治疗的情况下的药物治疗剂量:来自 IMPROVE HF 的报告。
Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.
8
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).心脏再同步治疗永久性心房颤动患者:来自心力衰竭门诊同步治疗试验(RAFT)的结果。
Circ Heart Fail. 2012 Sep 1;5(5):566-70. doi: 10.1161/CIRCHEARTFAILURE.112.968867. Epub 2012 Aug 14.
9
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.植入式心脏复律除颤器辅助或不辅助的心脏再同步治疗的长期成本效益
Eur Heart J. 2007 Jan;28(1):42-51. doi: 10.1093/eurheartj/ehl382. Epub 2006 Nov 16.
10
Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.心脏再同步化治疗联合除颤器治疗对合并或不合并室性心律失常的心力衰竭患者的益处。
J Am Coll Cardiol. 2006 Aug 1;48(3):464-70. doi: 10.1016/j.jacc.2006.04.072. Epub 2006 Jul 12.

引用本文的文献

1
Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions.用于各种心血管疾病患者运动处方和身体活动监测的可穿戴设备
CJC Open. 2025 Mar 3;7(5):695-706. doi: 10.1016/j.cjco.2025.02.017. eCollection 2025 May.
2
Physical Activity in Cardiac Implantable Electronic Device Recipients During the COVID-19 Pandemic.心脏植入式电子设备受者在 COVID-19 大流行期间的身体活动。
Mayo Clin Proc. 2022 Aug;97(8):1493-1500. doi: 10.1016/j.mayocp.2022.01.025. Epub 2022 Feb 2.
3
Comparative Analysis of Physical Activity Detected an External Accelerometer and Cardiac Implantable Electronic Devices.
使用外部加速度计和心脏植入式电子设备检测身体活动的比较分析。
Front Cardiovasc Med. 2022 May 27;9:898086. doi: 10.3389/fcvm.2022.898086. eCollection 2022.
4
Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review.加速度计评估的身体行为及其与植入式心脏复律除颤器接受者临床结局的关联:一项系统综述。
Cardiovasc Digit Health J. 2021 Nov 24;3(1):46-55. doi: 10.1016/j.cvdhj.2021.11.006. eCollection 2022 Feb.
5
The Association between Physical Activity and Cardiovascular Implantable Electronic Device-Detected Atrial High Rate Episodes.体力活动与心血管植入式电子设备检测到的心房高频率发作之间的关联
Acta Cardiol Sin. 2021 Nov;37(6):600-607. doi: 10.6515/ACS.202111_37(6).20210620A.
6
Lockdown measures for COVID-19 outbreak and variation in physical activity in patients with heart failure and cardiac implantable devices.新冠疫情封锁措施与心力衰竭及植入式心脏设备患者身体活动的变化
Int J Cardiol Heart Vasc. 2021 Dec;37:100906. doi: 10.1016/j.ijcha.2021.100906. Epub 2021 Oct 28.
7
Day-to-day measurement of physical activity and risk of atrial fibrillation.日常体力活动测量与心房颤动风险。
Eur Heart J. 2021 Oct 7;42(38):3979-3988. doi: 10.1093/eurheartj/ehab597.
8
Lockdown, slow down: impact of the COVID-19 pandemic on physical activity-an observational study.封城、减速:COVID-19 大流行对身体活动的影响——一项观察性研究。
Open Heart. 2021 Jun;8(1). doi: 10.1136/openhrt-2021-001600.
9
Remotely monitored inactivity due to COVID-19 lockdowns. Potential hazard for heart failure patients.因新冠疫情封锁导致的远程监测到的身体活动不足。对心力衰竭患者的潜在危害。
Saudi Med J. 2020 Nov;41(11):1211-1216. doi: 10.15537/smj.2020.11.25449.
10
Advances in accelerometry for cardiovascular patients: a systematic review with practical recommendations.心血管疾病患者加速度计的进展:一项带有实用建议的系统评价
ESC Heart Fail. 2020 Oct;7(5):2021-2031. doi: 10.1002/ehf2.12781. Epub 2020 Jul 3.